Linked Data Explorerhttp://worldcat.org/entity/work/id/7986995
Drug safety. Hearings before a subcommittee of the Committee on Government Operations, House of Representatives
Open All Close All
http://schema.org/description
- "Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs."
- "Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5."
- "Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide)."
- "Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4."
- "Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market."
- "Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex."
- "Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill."
http://schema.org/name
- "Drug safety. Hearings before a subcommittee of the Committee on Government Operations, House of Representatives"